作者: Melissa Kerkhof , Christa Benit , Alberto Duran-Pena , Charles J Vecht
DOI: 10.2217/CNS.15.29
关键词: Glioma 、 Anesthesia 、 Medicine 、 Brain tumor 、 Valproic Acid 、 Epilepsy 、 Oligodendroglial Tumor 、 Neurosurgery 、 Levetiracetam 、 Internal medicine 、 Oncology 、 Radiation therapy
摘要: Epilepsy develops in more than 70-90% of oligodendroglial tumors and represents a favorable indicator for long-term survival if present as the first clinical sign. Presence IDH1 mutation is frequently associated with seizures oligodendrogliomas, next to alterations glutamate GABA metabolism origin glioma-associated epilepsy. Treatment by surgery or radiotherapy results seizure freedom about two-thirds patients, chemotherapy reduction 50%. Symptomatic anticonvulsive therapy levetiracetam valproic acid monotherapy are both evidence-based drugs partial epilepsies, their effective use brain supported large amount additional data. Pharmacoresistance against anticonvulsants prevalent among occurring 40% despite polytherapy two more. Toxic signs involve cognition, bone marrow skin. Previous neurosurgery, radiation add risks cognitive dysfunction.